AbbVie

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and capabilities of a long-established pharmaceutical leader to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie employ approximately 21,000 people worldwide and markets medicines in more than 170 countries.

For further information on the company and its people, portfolio and commitments, please visit www.abbvie.co.uk and www.abbvie.com.

Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realise new science’s promise by bringing safe, effective medicines from the lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to help improve people’s lives.

For more information about Amgen, our pioneering science and our vital medicines, visit www.amgen.com

Amicus Therapeutics

Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus Amicus is committed to advancing and expanding a robust pipeline of cutting edge, first-or best-in class medicines for rare metabolic disease.

For more information about Amicus please visit the company’s website at www.amicusrx.com

Biogen

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Building on its heritage in biologics, Biogen also manufactures and commercializes high-quality biosimilars.

For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

Bristol Myers Squibb

Bristol Myers Squibb Pharmaceuticals Ltd (BMS) is a global BioPharma company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Around the world, our medicines help millions of patients in their fight against cancer, cardiovascular disease, diabetes, hepatitis B, HIV, rheumatoid arthritis and psychiatric disorders. BMS has a significant presence in the UK, with sites in Uxbridge and the North West of England, and a comprehensive clinical trials programme, in all stages of development, taking place across the country.

See www.b-ms.co.uk for more information.

Gilead

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, hepatitis, serious respiratory and cardiovascular conditions, cancer and inflammation. Gilead was founded in 1987 in Foster City, California and has become a leading biopharmaceutical company with a rapidly expanding product portfolio and approximately 5,000 employees in offices across four continents.

Please visit www.gilead.com/about/worldwide-operations/europe/united kingdom for more information.

Janssen

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases, vaccines, and cardiovascular and metabolic diseases. Driven by its commitment to patients, Janssen brings innovative products, services and solutions to people throughout the world. The legal entity for Janssen in the UK and Ireland is Janssen-Cilag Ltd.

Please visit www.janssen.com/uk for more information.

Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers — through medicines and information — for some of the world’s most urgent medical needs.

Lilly has a long heritage in the UK, opening its first facility outside North America in London in 1934. Today Lilly has around 700 talented employees in the UK working across two sites in roles such as regulatory affairs, medical affairs, marketing, and communications.

Additional information about Lilly is available at www.lilly.co.uk.

MSD

MSD believe the most important thing it makes is a difference. Through its prescription medicines, vaccines, biologic therapies, consumer care and animal health products, MSD works with customers and operates in more than 140 countries to bring innovative healthcare solutions to those who need them the most. MSD also demonstrate its commitment to increasing access to healthcare through far-reaching policies, programmes and partnerships. For more information, visit www.msd-uk.co.uk.

MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A.

Pfizer

Pfizer is the world’s largest research-based biopharmaceutical company, operating in 180 countries and employing more than 100,000 people worldwide. Pfizer has a diversified global health care portfolio which includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Pfizer is an industry leader in vaccines and biologics, and has a leading presence in inflammation and haemophilia. In the UK, Pfizer is a major supplier of medicines to the NHS with headquarters in Tadworth, Surrey. Pfizer has a strong research heritage in the country with R&D facilities in Cambridge undertaking studies at the forefront of current understanding in pain and regenerative medicine.

Please visit www.pfizer.co.uk to find out more.

1200px-Vertex_logo.svg

Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of cell and genetic therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.

Founded in 1989 in Cambridge, Mass., Vertex’s global headquarters is now located in Boston’s Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry’s top places to work, including 11 consecutive years on Science magazine’s Top Employers list and a best place to work for LGBTQ equality by the Human Rights Campaign.

Please visit www.vrtxpharma.co.uk to find out more.